By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Inventiva 

50 rue de Dijon

Daix    21121  France
Phone: 33-3-80-44-75-00 Fax: n/a


SEARCH JOBS

Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage whose objective is to develop and provide patients with new therapies. The focus of the company’s research and developmentdepartment targets three promising areas, namely fibrotic diseases, the treatment of certain forms of lysosomal diseases and oncology with a priority for the development of indications for orphan diseases for which the unmet medical need and the regulations in force allow an accelerated development.

YEAR FOUNDED:

2011

LEADERSHIP:

Founder and CEO: Frédéric Cren

Founder and CSO: Pierre Broqua

CFO: Jean Volatier

CMO: Jean-Louis Abitbol

JOBS:

Please click here for Inventiva job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW INVENTIVA:



Key Statistics


Email: info@inventivapharma.com
Ownership: Private

Web Site: Inventiva
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
Inventiva Release: Odiparcil Awarded Orphan Drug Designation For The Treatment Of MPS VI By The FDA 8/14/2017 7:38:55 AM
Inventiva To Present New Data On IVA337 At The 15th International Workshop On Scleroderma Research In Pittsburgh, USA 7/31/2017 9:39:56 AM
Inventiva Announces First-Half 2017 Financial And Corporate Update 7/6/2017 11:30:42 AM
Inventiva Announces New Compelling Data On Odiparcil / IVA336 To Be Presented At MPS Society National Conference 6/30/2017 9:12:03 AM
Inventiva Announces Peer Review Publication Of IVA337 Data In Pre-Clinical NASH Models 6/22/2017 11:31:20 AM
Inventiva To Present At The Jefferies 2017 Global Healthcare Conference 6/7/2017 1:57:56 PM
Dr Nanna Lüneborg, Principal Of Novo Ventures, Joins Inventiva's Board 5/30/2017 11:02:32 AM
Inventiva Announces Positive Results Of 12 Month Primate Toxicity Study With IVA337 5/16/2017 2:08:54 PM
Inventiva: First-Quarter 2017 Financial Update 4/26/2017 11:17:56 AM
Inventiva Announces Presentation Of Preclinical Results On IVA337 In NASH At The International Liver Congress 2017 (EASL) 4/20/2017 11:37:19 AM
12
//-->